Results 191 to 200 of about 100,418 (243)

Gadolinium Endofullerenes

Journal of Nanoscience and Nanotechnology, 2021
Fullerenes—A new combining atoms of carbon atoms into the molecule, which can serve as the parent and precursor of a whole class advanced organic compounds. Unsolved problems associated with a correct understanding of the structure, transformation, and behavior of the fullerene C60 molecule, make it impossible to interpret correctly many of its ...
Nazym Yerlanovna, Akhanova, Dmitry Viktorovich, Shchur, Anatoly Petrovich, Pomytkin, Alexander Dmitrievich, Zolotarenko, Anatoly Dmitrievich, Zolotarenko, Natalia Afanasievna, Gavrylyuk, Marzhan, Ualkhanova, Wang, Bo, Ding, Ang   +8 more
openaire   +2 more sources

Gadolinium toxicity and treatment

Magnetic Resonance Imaging, 2016
AbstractGadolinium based contrast agents (GBCAs) play an important role in the diagnostic evaluation of many patients. The safety of these agents has been once again questioned after gadolinium deposits were observed and measured in brain and bone of patients with normal renal function.
Joana Ramalho, Miguel Ramalho, Michael Jay   +2 more
exaly   +5 more sources

Hysterosalpingography with gadolinium

European Radiology, 2004
We report a case of diagnostic hysterosalpingography performed using gadoteric acid (1,350 mOsm) in a patient with a prior severe generalized adverse reaction to iodinated contrast media.
DE CARO, GIOVANNI, Ferraiolo A, Castelletti L, Anserini P, GORLERO, FRANCO   +4 more
openaire   +3 more sources

Comparative Pharmacokinetics of Gadolinium DTPA and Gadolinium Chloride

Investigative Radiology, 1988
An intravenous injection of 153Gd-labeled gadolinium-DTPA or gadolinium chloride was given to 60 rats, which were killed either 15, 40, 120, 300, 900, or 3600 seconds later. Tissue concentrations of gadolinium in the blood, liver, spleen, stomach, pancreas, renal cortex, renal medulla, lungs, heart, adrenals, gluteal muscle, fat, skin, thymus, brain ...
P B, Dean, P, Niemi, L, Kivisaari, M, Kormano   +3 more
openaire   +2 more sources

Gadolinium deposition in the brain

Magnetic Resonance Imaging, 2016
Gadolinium is highly toxic. Gadolinium-based contrast agents (GBCAs) consist of gadolinium ions and a chelating agent that binds the gadolinium ion tightly in order not to manifest its toxicity. Knowledge regarding gadolinium deposition in patients with normal renal function has advanced dramatically.
Tomonori Kanda, Yudai Nakai, Hiroshi Oba   +2 more
exaly   +3 more sources

Renal Tolerance of Gadolinium-DOTA and Gadolinium-DTPA in Rats

Investigative Radiology, 1994
Although gadolinium chelates are mainly eliminated by the kidney, there is limited information about their effects. The renal tolerance of these compounds on renal function in an in vivo rat model are evaluated.A combination of renal ischemia and intrarenal iodinated contrast agent infusion (diatrizoate) led to a reproducible and reversible model of ...
G, Brillet, M, Dubois, H, Beaufils, R, Bourbouze, G, Deray   +4 more
openaire   +2 more sources

Where does the gadolinium go? A review into the excretion and retention of intravenous gadolinium

Journal of Medical Imaging and Radiation Oncology, 2023
SummaryGadolinium‐based contrast agents (GBCAs) are commonly used in medical imaging. Most intravenously (IV) administered gadolinium is excreted via the kidneys, and pathological retention in renal failure leading to nephrogenic systemic fibrosis (NSF) is well described.
Pranav Sharma, Jeffrey Cheng, Alan Coulthard   +2 more
openaire   +3 more sources

Gadolinium-Induced Fibrosis

Annual Review of Medicine, 2016
Gadolinium-based contrast agents (GBCAs), once believed to be safe for patients with renal disease, have been strongly associated with nephrogenic systemic fibrosis (NSF), a severe systemic fibrosing disorder that predominantly afflicts individuals with advanced renal dysfunction.
Todd, Derrick J., Kay, Jonathan
openaire   +3 more sources

[Gadolinium deposition-"gadolinium deposition disease"].

Der Radiologe, 2019
Gadolinium (Gd)-based contrast agents have been routinely used worldwide in diagnostic MRI since 1988. All routinely applied contrast agents for clinical use were considered extremely safe with regard to tolerance, adverse effects and diagnostic efficacy and when used at Food and Drug Administration-approved doses.
P, Raczeck, P, Fries, A, Bücker, G, Schneider   +3 more
openaire   +1 more source

Residual or Retained Gadolinium

Radiology, 2016
International ...
Ben Salem, Douraied, Ognard, Julien, Guiu, Boris   +2 more
openaire   +3 more sources